Premature mortality in SWVA + NETN
Premature mortality through age 74, using CDC age-group midpoint weights and a reference age of 75.
Frame note: The age headline uses the broader all-cause CDC age pull. Total, trend, and cause figures use exact cells from the detailed cause-level frame; remaining suppressed values are not estimated.
Long-term direction
Key findings
- 2024 improved: YPLL75 fell 4.9% from 2023.
- Actual 2024 rate: 10,303 per 100K residents under 75, +14.9% versus 2010.
- Three causes dominate: cardiovascular disease, cancer, and accidents account for 59.9%.
- Average years lost per death declined: 15.7 in 2010 to 13.8 in 2024.
- Infant deaths: 66 in 2024, compared with 55 in 2023 and 77 in 2010.
Top YPLL75 drivers, 2010-2024
Largest 2023-2024 cause shifts
Target the places and populations carrying the greatest burden.
These views add denominator, age, rural/urban, and sex context to the cause-level findings on page 1.
Ages 55-64 alone account for 426.4K YPLL75, or 28.0% of the all-cause age total.
The under-75 population declined from 892,044 to 869,597, while total catchment population remained essentially unchanged.
Rural: 12,511 versus urban: 10,553 YPLL75 per 100K under-75 person-years. The rural death rate was 20.4% higher.
Male: 797.1K versus female: 475.2K YPLL75. This is a burden distribution, not a population-adjusted risk comparison.
The local observed rate was above all three benchmarks in each year from 2010 through 2024. Rates are crude, not age-adjusted.
Focus the prevention portfolio on three measurable aims.
Rural/urban results use the leadership-approved local planning classification of 18 rural and 5 urban county-equivalents. Rates use pooled annual Census residents under age 75.
Translate the leading YPLL75 causes into planning lanes.
These approaches are supported by the cited public-health guidance. They identify practical planning options but do not estimate local effect sizes or preventable deaths.
Major cardiovascular disease
Largest total YPLL75 in the broad-frame report.
- • Team-based hypertension care
- • Blood pressure control
- • Cholesterol management
- • Hypertension control rate
- • Statin use among eligible patients
Malignant neoplasms / cancer
Second-largest broad-frame YPLL75 driver; screening and vaccination lanes align with several preventable or earlier-detectable cancers.
- • Breast, cervical, colorectal, and lung cancer screening
- • Patient reminders and provider reminders
- • Patient navigation and community health workers
- • Screening completion by cancer type
- • Abnormal-result follow-up time
Accidents / unintentional injuries
Accidents rank third by YPLL75; poisoning/nontransport injuries and motor vehicle injuries explain much of accident-related YPLL75.
- • Medications for opioid use disorder
- • Naloxone distribution
- • Harm reduction
- • Naloxone kits distributed
- • MOUD initiation
Suicide
High YPLL per death means these deaths occur earlier in life and carry more lost years.
- • Comprehensive suicide prevention
- • 988 and crisis-care promotion
- • Suicide risk assessment and triage
- • Suicide deaths
- • ED visits for self-harm
Assign ownership, targets, cadence, and status.
Complete the fields before printing or saving the briefing as a PDF. Entries remain in this browser and do not change the verified mortality data.
Planning fields save in this browser. Export the completed tracker for team follow-up.